Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia

• Johannes Schetelig,
• Johannes Schetelig,
• Henning Baldauf,
• Linda Koster,
• Michelle Kuxhausen,
• Falk Heidenreich,
• Falk Heidenreich,
• Liesbeth C. de Wreede,
• Liesbeth C. de Wreede,
• Stephen Spellman,
• Michel van Gelder,
• Benedetto Bruno,
• Francesco Onida,
• Vinzenz Lange,
• Carolin Massalski,
• Victoria Potter,
• Per Ljungman,
• Nicolaas Schaap,
• Patrick Hayden,
• Stephanie J. Lee,
• Nicolaus Kröger,
• Kathy Hsu,
• Alexander H. Schmidt,
• Alexander H. Schmidt,
• Ibrahim Yakoub-Agha,
• Marie Robin

Affiliations

Johannes Schetelig

Medizinische Klinik und Poliklinik I, University Hospital Dresden, Dresden, Germany

Johannes Schetelig

DKMS Clinical Trials Unit, Dresden, Germany

Henning Baldauf

DKMS Clinical Trials Unit, Dresden, Germany

Linda Koster

EBMT Data Office Leiden, Leiden, Netherlands

Michelle Kuxhausen

Center for International Blood and Marrow Transplant Research, Minneapolis, MN, United States

Falk Heidenreich

Medizinische Klinik und Poliklinik I, University Hospital Dresden, Dresden, Germany

Falk Heidenreich

DKMS Clinical Trials Unit, Dresden, Germany

Liesbeth C. de Wreede

DKMS Clinical Trials Unit, Dresden, Germany

Liesbeth C. de Wreede

Leiden University Medical Center, Department of Biomedical Data Sciences, Leiden, Netherlands

Stephen Spellman

Center for International Blood and Marrow Transplant Research, Minneapolis, MN, United States

Michel van Gelder

Maastricht University Medical Center, Department of Internal Medicine, Maastricht, Netherlands

Benedetto Bruno

A.O.U. Citta della Salute e della Scienza di Torino, Turin, Italy

Francesco Onida

Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy

Vinzenz Lange

DKMS Life Science Lab, Dresden, Germany

Carolin Massalski

DKMS Life Science Lab, Dresden, Germany

Victoria Potter

0GKT School of Medicine, London, United Kingdom

Per Ljungman

1Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Nicolaas Schaap

2Radboud University Medical Centre, Nijmegen, Netherlands

Patrick Hayden

3St. James’s Hospital, Dublin, Ireland

Stephanie J. Lee

4Fred Hutchinson Cancer Research Center, Seattle, WA, United States

Nicolaus Kröger

5University Hospital Eppendorf, Hamburg, Germany

Kathy Hsu

6Memorial Sloan Kettering Cancer Center, New York & Scientific Director, CIBMTR Immunobiology Working Committee, New York City, NY, United States

Alexander H. Schmidt

DKMS Clinical Trials Unit, Dresden, Germany

Alexander H. Schmidt

DKMS Life Science Lab, Dresden, Germany

Ibrahim Yakoub-Agha

7CHU de Lille, LIRIC, INSERM U995, Universite´ de Lille, Lille, France

Marie Robin

8Hopital Saint-Louis, APHP, Universite´ de Paris, Paris, France